We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Nanotechnology Detects Molecular Biomarker for Osteoarthritis

News   Mar 13, 2018 | Original Story from Wake Forest Baptist Medical Center.

 
Nanotechnology Detects Molecular Biomarker for Osteoarthritis

Adam Hall, assistant professor of biomedical engineering at Wake Forest School of Medicine, injects microliters of fluid into a flow cell holding a nanopore device that has demonstrated the ability to detect molecular biomarkers of disease. Credit: Wake Forest Baptist Medical Center Photography.

 
 
 

RELATED ARTICLES

Study Finds Commercially Available Antibodies Are Not Binding Their Target

News

In a new study, researchers have tested the binding specificity of commercial antibodies to the C9ORF72 protein, and explored a novel validation approach.

READ MORE

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

How Do Empty Spaces Make a Protein Unstable?

News

Partial unfolding of proteins may affect their stability and is a challenge in the industry. So how does a cavity destabilize a protein? Would such a cavity be empty? These are questions that researchers from Aarhus University answer in a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE